Article
Exploring Physicians’ Knowledge, Attitudes, and Practices Regarding SGLT2 Inhibitors among diabetic patients in the North West Bank of Palestine
2026-04-07
Abstract excerpt
<title>Abstract</title> <p>Background Sodium–glucose cotransporter 2 (SGLT2) inhibitors improve outcomes in type 2 diabetes mellitus (T2DM) and are now recommended for cardio-renal protection in appropriate patients. Evidence from Palestine on physicians’ preparedness to prescribe SGLT2 inhibitors is limited. Methods We conducted a descriptive cross-sectional online survey (October 2025–February 2026) among phy...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5b4920df-eb9c-514c-b464-48c07dfa64e1
- DOI
- 10.21203/rs.3.rs-9051294/v1
